Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Withdrawn 2Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Kidney Neoplasms 2Carcinoma, Renal Cell 2

Interventions

Sunitinib 3Radiotherapy 3Cryosurgery 3pembrolizumab 2fludarabine phosphate 2Peripheral Blood Stem Cell Transplantation 2Nephrectomy 22-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 2siltuximab 1avelumab 1Thalidomide 1Tacrolimus 1Suspensions 1Radiosurgery 1Radiofrequency Ablation 1Propranolol 1Powders 1PT-100 dipeptide 1Mycophenolic Acid 1Iodine 1Introns 1Interleukin-2 1Immunohistochemistry 1Genistein 1Gene Expression Profiling 1G250 monoclonal antibody 1Flow Cytometry 1Etoposide 1Docetaxel 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × Kidney Neoplasms × Nephrectomy × Clear all
NCT03189186 2021-04-05

Phase-I Trial of Pembrolizumab and Percutaneous Cryoablation Combination Followed by Nephron-Sparing Surgery or Cytoreductive Nephrectomy in Locally Advanced and Metastatic Renal Cell Carcinomas

University of California, Irvine

Phase 1 Withdrawn
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT01070186 2012-07-31

Study of Sunitinib in Subjects With High Risk Renal Cell Carcinoma

Jonsson Comprehensive Cancer Center

Phase 2 Withdrawn
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡